Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Immutep S.a.s.

Clinical trials sponsored by Immutep S.a.s., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug combo aims to extend life in advanced lung cancer Results expected Jun 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 1 Completed 2 Terminated 1

New antibody IMP761 tested for safety in healthy volunteers

Knowledge-focused Recruiting now

This early-phase trial tests whether a new drug called IMP761 is safe and tolerable in 79 healthy adults aged 18-55. Participants receive either IMP761 or a placebo intravenously, along with a harmless immune challenge (KLH) to see how the drug affects immune responses. The study…

Phase 1 • Sponsor: Immutep S.A.S. • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:23 UTC